IL6R and Autoimmunity: Disruption of the IL-6/IL-6R interaction upstream of STAT3 via the anti-IL-6R monoclonal antibody tocilizumab was shown to partially improve autoimmunity [82, 85] by increasing FoxP3 + Treg cells [142].